Ruthenium(II)–Arene RAPTA Type Complexes Containing Curcumin and Bisdemethoxycurcumin Display Potent and Selective Anticancer Activity

A series of novel ruthenium­(II) arene RAPTA type derivatives (arene = cymene, hexamethylbenzene) containing curcumin-based ligands (curcH = curcumin, bdcurcH = bisdemethoxycurcumin) and PTA (1,3,5-triaza-7-phosphaadamantane) have been synthesized and fully characterized. The solid-state structures...

Full description

Saved in:
Bibliographic Details
Published in:Organometallics 2014-07, Vol.33 (14), p.3709-3715
Main Authors: Pettinari, Riccardo, Marchetti, Fabio, Condello, Francesca, Pettinari, Claudio, Lupidi, Giulio, Scopelliti, Rosario, Mukhopadhyay, Suman, Riedel, Tina, Dyson, Paul J
Format: Article
Language:English
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:A series of novel ruthenium­(II) arene RAPTA type derivatives (arene = cymene, hexamethylbenzene) containing curcumin-based ligands (curcH = curcumin, bdcurcH = bisdemethoxycurcumin) and PTA (1,3,5-triaza-7-phosphaadamantane) have been synthesized and fully characterized. The solid-state structures of [Ru­(cym)­(curc)­(PTA)]­[SO3CF3], [Ru­(hmb)­(curc)­(PTA)]­[SO3CF3], and [Ru­(hmb)­(bdcurc)­(PTA)]­[SO3CF3] have been determined by single-crystal X-ray diffraction. The antitumor activity of the complexes has been evaluated in vitro against human ovarian carcinoma cells (A2780 and A2780cisR), as well as against nontumorous human embryonic kidney (HEK293) cells. The correlation of the cytotoxicity upon switching the curcumin-based ligands, i.e. curcumin vs bisdemethoxycurcumin, is not straightforward. In contrast, the PTA ligand greatly enhances the activity and selectivity of ruthenium compounds in comparison to previously reported compounds.
ISSN:0276-7333
1520-6041
DOI:10.1021/om500317b